Diampa M 12.5/500mg Tablet
Diampa M 12.5/500mg Tablet
Diampa M 12.5/500mg Tablet
Diampa M 12.5/500mg Tablet

Diampa M 12.5/500mg Tablet – Empagliflozin 12.5mg + Metformin 500mg Dual Therapy for Type 2 Diabetes

  • Gentle yet effective Empagliflozin 12.5mg + Metformin 500mg combo
  • Cardio-renal protection + weight-friendly diabetes management
In stock
9 People are viewing this right now
Sale price Rs.530.00 PKR
Add to Wishlist

Diampa M 12.5/500mg Tablet

Diampa M 12.5/500mg Tablet – Empagliflozin 12.5mg + Metformin 500mg Dual Therapy for Type 2 Diabetes

Rs.530.00

Diampa M 12.5/500mg Tablet – Perfect Starting-Strength Combination for Effective Glucose Control

Diampa M 12.5/500mg Tablet brings together Empagliflozin 12.5mg and Metformin 500mg in one film-coated tablet, offering a balanced and well-tolerated dual mechanism for adults newly stepping up from metformin monotherapy. Empagliflozin drives excess sugar out through urine while metformin reduces hepatic glucose output and enhances insulin utilization, resulting in meaningful HbA1c drops, gentle weight reduction, and the renowned cardiovascular and renal protective effects of the SGLT2 class – all with a lower metformin dose that minimizes early gastrointestinal discomfort.

  • Delivers balanced HbA1c reduction ideal for early combination therapy
  • Clinically proven protection against heart failure and kidney disease progression
  • Promotes sustainable weight loss without stimulating appetite
  • Lower metformin strength improves initial tolerability
  • Twice-daily regimen supports steady 24-hour glucose control

  1. Take one tablet twice daily with or just after meals to improve gastrointestinal tolerance
  2. Swallow whole with water – do not crush, break, or chew the tablet
  3. Stick to your personalized diet and physical activity schedule
  4. Perform regular home blood glucose monitoring as instructed
  5. Keep regular doctor appointments for kidney function and overall diabetes review

Q1: Is Diampa M 12.5/500 suitable for newly diagnosed patients?
A1: Yes – the moderate metformin dose makes it an excellent step-up option with reduced initial stomach upset.

Q2: How soon can I expect to see weight changes?
A2: Most patients notice 1–3 kg weight loss within the first 4–8 weeks due to urinary calorie loss.

Q3: Does this strength still offer heart and kidney benefits?
A3: Absolutely – Empagliflozin 12.5mg provides the same clinically proven cardio-renal protection as the 25mg dose.

Q4: Can I take it if I sometimes forget morning doses?
A4: Twice-daily dosing offers flexibility; just take the missed dose as soon as remembered unless it’s almost time for the next one.

Q5: Will it cause more stomach issues than plain metformin?
A5: No – many patients actually tolerate it better because food timing and the combination help ease GI symptoms.

Q1: Is Diampa M 12.5/500 suitable for newly diagnosed patients?
A1: Yes – the moderate metformin dose makes it an excellent step-up option with reduced initial stomach upset.

Q2: How soon can I expect to see weight changes?
A2: Most patients notice 1–3 kg weight loss within the first 4–8 weeks due to urinary calorie loss.

Q3: Does this strength still offer heart and kidney benefits?
A3: Absolutely – Empagliflozin 12.5mg provides the same clinically proven cardio-renal protection as the 25mg dose.

Q4: Can I take it if I sometimes forget morning doses?
A4: Twice-daily dosing offers flexibility; just take the missed dose as soon as remembered unless it’s almost time for the next one.

Q5: Will it cause more stomach issues than plain metformin?
A5: No – many patients actually tolerate it better because food timing and the combination help ease GI symptoms.

Empagliflozin, Metformin Hydrochloride, Microcrystalline Cellulose, Povidone K30, Crospovidone, Colloidal Anhydrous Silica, Magnesium Stearate, Hypromellose, Titanium Dioxide, Macrogol/PEG, Talc, Iron Oxide Red & Yellow

  • Contraindicated in type 1 diabetes and diabetic ketoacidosis
  • Rare but serious risk of lactic acidosis – avoid if eGFR <30 mL/min or during acute illness
  • Maintain adequate fluid intake to lower dehydration risk from Empagliflozin
  • Watch for signs of genital mycotic infections or urinary tract infections
  • Long-term metformin use may reduce vitamin B12 absorption – annual checking recommended
  • Store in a cool, dry place below 30°C away from children

Recently viewed products